Cargando…
Immunohistochemical Expression of Programmed Death Ligand 1 in Oral Extranodal Diffuse Large B Cell Lymphoma
Objective Lymphomas are the third most common cancer after squamous cell carcinoma and salivary gland tumors. Extranodal diffuse B cell lymphoma (DBCL) represents 30 to 58% of non-Hodgkin's lymphoma. One of the major problems of DBCL is the high likelihood of disease relapse following treatmen...
Autores principales: | Said, Rania Hanafi Mahmoud, Hussein, Fatma F., El-Deeb, Amal M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329535/ https://www.ncbi.nlm.nih.gov/pubmed/35944575 http://dx.doi.org/10.1055/s-0042-1747951 |
Ejemplares similares
-
Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma
por: HAN, LIJUAN, et al.
Publicado: (2014) -
An Extranodal Site of Diffuse Large B-cell Lymphoma Presenting as Ovarian Cancer
por: Jaouani, Laila, et al.
Publicado: (2023) -
Multifocal Extranodal Involvement of Diffuse Large B-Cell Lymphoma
por: Cabuk, Devrim, et al.
Publicado: (2013) -
Extranodal diffuse non hodgkin lymphoma in the thigh
por: Bölke, E, et al.
Publicado: (2010) -
Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma
por: Nagai, Shin, et al.
Publicado: (2018)